{"context":{"query":">>mondo>>clinical_trials","source_dataset":"mondo","target_dataset":"clinical_trials"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0004979,73,MONDO:0004979,161,0]["},"schema":"id|brief_title|overall_status|phase|study_type","mappings":[{"input":"MONDO:0004979","source":"MONDO:0004979|asthma","targets":["NCT00070707|Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00071552|Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients|TERMINATED|PHASE4|INTERVENTIONAL","NCT00096954|A Prospective, Randomized, Double-Blind Study of the Efficacy of Omalizumab (Xolair) in Atopic Asthmatics With Good Lung Capacity Who Remain Difficult to Treat (EXACT)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00102765|Study Of Asthma In Patients Of African Descent|COMPLETED|PHASE4|INTERVENTIONAL","NCT00102882|Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate|COMPLETED|PHASE4|INTERVENTIONAL","NCT00124176|Continuous Levalbuterol for Treatment of Status Asthmaticus in Children|COMPLETED|PHASE4|INTERVENTIONAL","NCT00133042|The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00140881|A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00140946|A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00148408|Trial of Asthma Patient Education (TAPE)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00152984|Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00153075|Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00156819|The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial|COMPLETED|PHASE4|INTERVENTIONAL","NCT00157937|A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00169546|Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.|COMPLETED|PHASE4|INTERVENTIONAL","NCT00172341|Sublingual Immunotherapy With House Dust Mite Extract in Asthmatic Children|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00189436|Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children|COMPLETED|PHASE4|INTERVENTIONAL","NCT00196547|Montelukast in Modulating Exacerbations of Asthma in Children|COMPLETED|PHASE4|INTERVENTIONAL","NCT00197106|Treatment Of Symptomatic Asthma In Children|COMPLETED|PHASE4|INTERVENTIONAL","NCT00228475|A Study to Assess the Concentration of Budesonide in Breast Milk From Asthmatic Women|COMPLETED|PHASE4|INTERVENTIONAL","NCT00234390|PreAsthmaControl (PAC)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00235053|Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID|COMPLETED|PHASE4|INTERVENTIONAL","NCT00237068|A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00238888|Randomised Controlled Trial of a Multi-faceted Community-based Intervention to Improve Asthma in Children|COMPLETED|PHASE4|INTERVENTIONAL","NCT00238927|Clinical Trial of Fluticasone Versus Placebo at the Onset of a Cold for Children With Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00242411|MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults|COMPLETED|PHASE4|INTERVENTIONAL","NCT00250263|A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) Allergy|COMPLETED|PHASE4|INTERVENTIONAL","NCT00250341|Non-invasive Measures of Distal Lung Disease in Asthmatics|COMPLETED|PHASE4|INTERVENTIONAL","NCT00257933|Oral Prednisolone Dosing in Children Hospitalized With Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00262587|Elite Sport and Development of Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00264849|Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00267917|Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique.|COMPLETED|PHASE4|INTERVENTIONAL","NCT00272753|Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations|COMPLETED|PHASE4|INTERVENTIONAL","NCT00273026|Study In Asthma Control|TERMINATED|PHASE4|INTERVENTIONAL","NCT00273962|A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00291382|Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination Product|COMPLETED|PHASE4|INTERVENTIONAL","NCT00292838|Relative Potency of Inhaled Corticosteroids|COMPLETED|PHASE4|INTERVENTIONAL","NCT00296491|Study Of Allergic Rhinitis In Patients Who Also Have Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00296530|Study Of Patients With Allergic Rhinitis And Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00307970|Impact of Anti-static Chamber/Mask|COMPLETED|PHASE4|INTERVENTIONAL","NCT00308932|Effect of Age and Device on Delivery of Fluticasone|COMPLETED|PHASE4|INTERVENTIONAL","NCT00315744|Viapaed Study In Children And Adolescents With Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00327353|Influence Of Different Airflow Resistances On Drug Effect Of 50μg Salmeterol And 6 μg Formoterol|COMPLETED|PHASE4|INTERVENTIONAL","NCT00329381|Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT00351143|A Comparative Study To Determine If Motivating Asthma Education (Compliance Enhancement) Has An Effect On Asthma Control|COMPLETED|PHASE4|INTERVENTIONAL","NCT00353873|Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids|COMPLETED|PHASE4|INTERVENTIONAL","NCT00363480|Results Of Patient Rated Asthma Control Test In Comparison To Diary Card Data|COMPLETED|PHASE4|INTERVENTIONAL","NCT00367016|Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00368342|Chronic Bronchiolitis or Resistant Asthma?|COMPLETED|PHASE4|INTERVENTIONAL","NCT00370591|Study Of Airway Physiology In Adults. SERETIDE DISKUS® Inhaler and FLIXOTIDE® Inhaler Are Trademarks of GSK Croup of Companies.|COMPLETED|PHASE4|INTERVENTIONAL","NCT00377364|Acetaminophen (Tylenol) for Mood and Memory Changes Associated With Corticosteroid Therapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT00377572|Inner-City Anti-IgE Therapy for Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00380484|Short- and Long Term Growth in Children With Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00380705|Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00381355|RCT of a Written Action Plan vs. Usual Care in Children With Acute Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00385359|A Pilot Efficacy Study of Inhaled Albuterol Delivered With Akita Breath Control|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00393367|Budesonide Inhalation Suspension for Acute Asthma in Children|COMPLETED|PHASE4|INTERVENTIONAL","NCT00394355|Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00395239|Asthma/Steroid Withdrawal Study|TERMINATED|PHASE4|INTERVENTIONAL","NCT00395408|Linear Growth Study (0476-097)(COMPLETED)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00400608|A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS|COMPLETED|PHASE4|INTERVENTIONAL","NCT00404261|Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD).|COMPLETED|PHASE4|INTERVENTIONAL","NCT00404547|Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The ACCEPT-study (BY9010/CA-102)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00411346|Patient Research In Self-Management of Asthma (PRISMA)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00440245|Bronchoprotection of Salbutamol in Asthma and Chronic Obstructive Pulmonary Disease|COMPLETED|PHASE4|INTERVENTIONAL","NCT00442013|Lansoprazole to Treat Children With Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00442351|Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler Versus Placebo in Mild/Moderate Persistent Asthmatics (Study P04654)(TERMINATED)|TERMINATED|PHASE4|INTERVENTIONAL","NCT00442559|Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00446056|Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00452348|A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00452699|A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00453765|The Effect of Montelukast in Patients With Chronic Cough and Bronchial Hyperreactivity|COMPLETED|PHASE4|INTERVENTIONAL","NCT00453778|A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT00454051|Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00455923|SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00456313|No Resistance After Long Term Treatment SERETIDE|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT00461500|SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults|COMPLETED|PHASE4|INTERVENTIONAL","NCT00461812|A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma|TERMINATED|PHASE4|INTERVENTIONAL","NCT00463866|Local Phase 4 Pan-European SMART Study|COMPLETED|PHASE4|INTERVENTIONAL","NCT00471809|Childhood Asthma Research and Education (CARE) Network Trial - Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma (MARS)|TERMINATED|PHASE4|INTERVENTIONAL","NCT00476736|The Effect of N-Acetylcystein on Quality of Life and Air Trapping During Rest and After Exercise|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00479739|CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.|COMPLETED|PHASE4|INTERVENTIONAL","NCT00480649|Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00486343|Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICS|TERMINATED|PHASE4|INTERVENTIONAL","NCT00487773|Effect of Different Doses of Budesonide on Markers of Bone Metabolism in Children With Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00490243|Effect of Different Anti-Asthmatic Treatments on Lung Function and on Exercise-Induced Bronchoconstriction in Children With Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00495612|A Study of Omalizumab in Preventing Bronchoconstriction Following Environmental Cat Dander Exposure in Patients With Cat Dander-induced Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00496561|Effect of Specific Immunotherapy to Dust Mites in Children With Asthma|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00496574|Evaluation of Efficacy of House Dust Mite Immunotherapy in Children With Bronchial Asthma|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00500253|Assessment of Utility of Exhaled Nitric Oxide Measurement for Treatment Monitoring in Children With Asthma|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00503009|Study Of RV-39 In Patients Who Also Have Asthma|TERMINATED|PHASE4|INTERVENTIONAL","NCT00517634|Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects|COMPLETED|PHASE4|INTERVENTIONAL","NCT00518518|Safety and Efficacy of Ultra-Rush Sublingual Immunotherapy in Children With Asthma Allergic to Grass Pollen|COMPLETED|PHASE4|INTERVENTIONAL","NCT00521599|A Study of the Equivalent Effectiveness of 400 mcg Mometasone Furoate Using Two Different Dry Powder Inhalers in Moderate Asthmatics (Study P04828)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00522782|Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children|COMPLETED|PHASE4|INTERVENTIONAL","NCT00525512|Tiotropium In Exercise|COMPLETED|PHASE4|INTERVENTIONAL","NCT00530062|Comparison of Single-Dose Efficacy of an Albuterol Breath-Actuated Inhaler (Albuterol-HFA-BAI) Versus an Albuterol Metered-Dose Inhaler (Albuterol-HFA-MDI) in Participants With Asthma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00545324|First Step With Singulair® Therapy (0476-323)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00545844|Singulair(R) In Asthma And Allergic Rhinitis (0476-383)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00546143|Safety and Tolerability of Omalizumab in Patients With Mild to Moderate Asthma|COMPLETED|PHASE4|INTERVENTIONAL"]}]}